Published in J Virol on November 01, 1991
Distinct PrP properties suggest the molecular basis of strain variation in transmissible mink encephalopathy. J Virol (1994) 5.12
Immunohistochemical detection of prion protein in lymphoid tissues of sheep with natural scrapie. J Clin Microbiol (1996) 2.26
Rapid prion neuroinvasion following tongue infection. J Virol (2003) 2.06
Abnormal isoform of prion proteins accumulates in the synaptic structures of the central nervous system in patients with Creutzfeldt-Jakob disease. Am J Pathol (1992) 1.86
Ectopic expression of prion protein (PrP) in T lymphocytes or hepatocytes of PrP knockout mice is insufficient to sustain prion replication. Proc Natl Acad Sci U S A (1999) 1.81
The sequential development of abnormal prion protein accumulation in mice with Creutzfeldt-Jakob disease. Am J Pathol (1992) 1.66
The nasal cavity is a route for prion infection in hamsters. J Virol (2007) 1.46
Astrocyte-specific expression of hamster prion protein (PrP) renders PrP knockout mice susceptible to hamster scrapie. EMBO J (1997) 1.36
How do follicular dendritic cells interact intimately with B cells in the germinal centre? Immunology (2005) 1.35
Tumor necrosis factor alpha-deficient, but not interleukin-6-deficient, mice resist peripheral infection with scrapie. J Virol (2000) 1.34
Follicular dendritic cells and dissemination of Creutzfeldt-Jakob disease. J Virol (2000) 1.32
PrP-dependent association of prions with splenic but not circulating lymphocytes of scrapie-infected mice. EMBO J (1999) 1.28
Retrograde transport of transmissible mink encephalopathy within descending motor tracts. J Virol (2002) 1.28
Tunnelling nanotubes: a highway for prion spreading? Prion (2009) 1.22
B cells and platelets harbor prion infectivity in the blood of deer infected with chronic wasting disease. J Virol (2010) 1.21
Prion uptake in the gut: identification of the first uptake and replication sites. PLoS Pathog (2011) 1.21
Hydrated autoclave pretreatment enhancement of prion protein immunoreactivity in formalin-fixed bovine spongiform encephalopathy-affected brain. Acta Neuropathol (1994) 1.17
Immune system-dependent and -independent replication of the scrapie agent. J Virol (1996) 1.13
The immunobiology of prion diseases. Nat Rev Immunol (2013) 1.13
B lymphocyte-restricted expression of prion protein does not enable prion replication in prion protein knockout mice. Proc Natl Acad Sci U S A (2001) 1.10
Efficient lymphoreticular prion propagation requires PrP(c) in stromal and hematopoietic cells. J Virol (2001) 1.10
Progress and problems in the biology, diagnostics, and therapeutics of prion diseases. J Clin Invest (2004) 1.09
Repetitive immunization enhances the susceptibility of mice to peripherally administered prions. PLoS One (2009) 1.07
Epithelial and endothelial expression of the green fluorescent protein reporter gene under the control of bovine prion protein (PrP) gene regulatory sequences in transgenic mice. Proc Natl Acad Sci U S A (2000) 1.01
Neuroinvasion by a Creutzfeldt-Jakob disease agent in the absence of B cells and follicular dendritic cells. Proc Natl Acad Sci U S A (2001) 0.99
Deletion of beta-strand and alpha-helix secondary structure in normal prion protein inhibits formation of its protease-resistant isoform. J Virol (2001) 0.98
Prion infection of muscle cells in vitro. J Virol (2007) 0.97
Processing and degradation of exogenous prion protein by CD11c(+) myeloid dendritic cells in vitro. J Virol (2002) 0.94
The primary structure of the prion protein influences the distribution of abnormal prion protein in the central nervous system. Am J Pathol (1992) 0.94
Human prions and plasma lipoproteins. Proc Natl Acad Sci U S A (2006) 0.93
Accumulation of abnormal prion protein in mice infected with Creutzfeldt-Jakob disease via intraperitoneal route: a sequential study. Am J Pathol (1993) 0.92
Orally administered prion protein is incorporated by m cells and spreads into lymphoid tissues with macrophages in prion protein knockout mice. Am J Pathol (2011) 0.90
A new prion disease: relationship with central and peripheral amyloidoses. Nat Rev Neurol (2015) 0.87
CD21-positive follicular dendritic cells: A possible source of PrPSc in lymph node macrophages of scrapie-infected sheep. Am J Pathol (2003) 0.85
Immunohistochemical characterization of cell types expressing the cellular prion protein in the small intestine of cattle and mice. Histochem Cell Biol (2006) 0.84
Prion diseases and the gastrointestinal tract. Can J Gastroenterol (2006) 0.83
Infectious particles, stress, and induced prion amyloids: a unifying perspective. Virulence (2013) 0.82
Test for detection of disease-associated prion aggregate in the blood of infected but asymptomatic animals. Clin Vaccine Immunol (2006) 0.82
Complement protein C3 exacerbates prion disease in a mouse model of chronic wasting disease. Int Immunol (2013) 0.82
Immunomodulation for prion and prion-related diseases. Expert Rev Vaccines (2010) 0.80
Creutzfeldt-Jakob disease with amyloid angiopathy: diagnosis by immunological analyses and transmission experiments. Acta Neuropathol (1992) 0.80
Lymphotoxin, but not TNF, is required for prion invasion of lymph nodes. PLoS Pathog (2012) 0.80
PrP antibody binding-induced epitope modulation evokes immunocooperativity. J Neuroimmunol (2008) 0.80
Interaction between dendritic cells and nerve fibres in lymphoid organs after oral scrapie exposure. Virchows Arch (2007) 0.80
Detection and control of prion diseases in food animals. ISRN Vet Sci (2012) 0.80
Could immunomodulation be used to prevent prion diseases? Expert Rev Anti Infect Ther (2012) 0.80
Oral infection by the bovine spongiform encephalopathy prion. Proc Natl Acad Sci U S A (1999) 0.78
Follicular dendritic cell disruption as a novel mechanism of virus-induced immunosuppression. Proc Natl Acad Sci U S A (2016) 0.78
Biological network inferences for a protection mechanism against familial Creutzfeldt-Jakob disease with E200K pathogenic mutation. BMC Med Genomics (2014) 0.77
Expression of cellular prion protein (PrP(c)) in schizophrenia, bipolar disorder, and depression. J Neural Transm (Vienna) (2008) 0.77
Characterization of variant Creutzfeldt-Jakob disease prions in prion protein-humanized mice carrying distinct codon 129 genotypes. J Biol Chem (2013) 0.77
Species barrier prevents an abnormal isoform of prion protein from accumulating in follicular dendritic cells of mice with Creutzfeldt-Jakob disease. J Virol (1993) 0.76
Prions and lymphoid organs: solved and remaining mysteries. Prion (2013) 0.75
Genomic Characteristics of Genetic Creutzfeldt-Jakob Disease Patients with V180I Mutation and Associations with Other Neurodegenerative Disorders. PLoS One (2016) 0.75
Grafting mouse brains: from neurocarcinogenesis to neurodegeneration. EMBO J (1998) 0.75
Recent developments in the pathogenesis, diagnosis, and therapy of prion diseases. Dialogues Clin Neurosci (2001) 0.75
Pyrene conjugation and spectroscopic analysis of hydroxypropyl methylcellulose compounds successfully demonstrated a local dielectric difference associated with in vivo anti-prion activity. PLoS One (2017) 0.75
Novel proteinaceous infectious particles cause scrapie. Science (1982) 24.09
A severe combined immunodeficiency mutation in the mouse. Nature (1983) 13.99
Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution. J Exp Med (1973) 13.88
The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function. Science (1988) 9.05
Identification of a novel cell type in peripheral lymphoid organs of mice. II. Functional properties in vitro. J Exp Med (1974) 7.58
Formic acid pretreatment enhances immunostaining of cerebral and systemic amyloids. Lab Invest (1987) 4.98
Pathogenesis of scrapie virus infection in the mouse. J Infect Dis (1967) 3.34
Follicular dendritic cells and virus-like particles in AIDS-related lymphadenopathy. Lancet (1984) 3.01
Changes in the localization of brain prion proteins during scrapie infection. Neurology (1987) 2.27
Transmission of chronic spongiform encephalopathy with kuru plaques from humans to small rodents. Ann Neurol (1979) 2.01
Prions and neurodegenerative diseases. N Engl J Med (1987) 1.76
Detection of scrapie-associated fibril (SAF) proteins using anti-SAF antibody in non-purified tissue preparations. J Gen Virol (1986) 1.67
Pathogenesis of scrapie in the mouse: the role of the spleen. Nature (1970) 1.58
Immunohistochemical confirmation of Creutzfeldt-Jakob disease with a long clinical course with amyloid plaque core antibodies. Am J Pathol (1988) 1.52
Studies of the lymphoreticular system in the pathogenesis of scrapie: the role of spleen and thymus. J Comp Pathol (1978) 1.47
Scrapie-associated prion protein accumulates in astrocytes during scrapie infection. Proc Natl Acad Sci U S A (1991) 1.45
Mechanisms of dendritic cell function. Immunol Today (1990) 1.39
Creutzfeldt-Jakob disease in mice: persistent viremia and preferential replication of virus in low-density lymphocytes. Infect Immun (1983) 1.37
Follicular dendritic cells in suspension: identification, enrichment, and initial characterization indicating immune complex trapping and lack of adherence and phagocytic activity. J Immunol (1985) 1.33
Organ distribution of proteinase-resistant prion protein in humans and mice with Creutzfeldt-Jakob disease. J Gen Virol (1989) 1.24
N-terminal sequence of prion protein is also integrated into kuru plaques in patients with Gerstmann-Sträussler syndrome. Brain Res (1991) 1.23
Replication of Aleutian mink disease parvovirus in lymphoid tissues of adult mink: involvement of follicular dendritic cells and macrophages. J Virol (1991) 1.17
Direct intrafollicular differentiation of memory B cells into plasma cells. Immunol Today (1990) 1.11
Development of follicular dendritic cells in lymph nodes of B-cell-depleted mice. Cell Tissue Res (1988) 1.11
Isolation from mouse spleen of cell populations with high specific infectivity for scrapie virus. Infect Immun (1972) 1.11
Experimental transmission of human subacute spongiform encephalopathy to small rodents. III. Further transmission from three patients and distribution patterns of lesions in mice. Acta Neuropathol (1981) 1.09
Immunoreactivity of a synthetic pentadecapeptide corresponding to the N-terminal region of the scrapie prion protein. J Gen Virol (1986) 1.03
Western blot detection of scrapie-associated fibril protein in tissues outside the central nervous system from preclinical scrapie-infected mice. J Gen Virol (1988) 1.03
Host genetic control of incubation periods of Creutzfeldt-Jakob disease in mice. J Gen Virol (1989) 0.91
Selective elimination of double-positive immature thymocytes by a thymic epithelial cell line. Eur J Immunol (1990) 0.88
Lack of effect of thymus and spleen on the incubation period of Creutzfeldt-Jakob disease in mice. J Gen Virol (1987) 0.85
A novel MHC class I-related molecule expressed on mouse thymic stroma cells and mature lymphocytes. Immunogenetics (1991) 0.84
Formic acid pretreatment enhances immunostaining of cerebral and systemic amyloids. Lab Invest (1987) 4.98
Beta-protein amyloid is widely distributed in the central nervous system of patients with Alzheimer's disease. Am J Pathol (1989) 2.61
Pro----leu change at position 102 of prion protein is the most common but not the sole mutation related to Gerstmann-Sträussler syndrome. Biochem Biophys Res Commun (1989) 2.35
Transmission of chronic spongiform encephalopathy with kuru plaques from humans to small rodents. Ann Neurol (1979) 2.01
Vascular variant of prion protein cerebral amyloidosis with tau-positive neurofibrillary tangles: the phenotype of the stop codon 145 mutation in PRNP. Proc Natl Acad Sci U S A (1996) 1.94
Prion protein of 106 residues creates an artifical transmission barrier for prion replication in transgenic mice. Cell (1999) 1.87
Abnormal isoform of prion proteins accumulates in the synaptic structures of the central nervous system in patients with Creutzfeldt-Jakob disease. Am J Pathol (1992) 1.86
Amyloid plaques in Creutzfeldt-Jakob disease stain with prion protein antibodies. Ann Neurol (1986) 1.85
Typing prion isoforms. Nature (1997) 1.82
Hydrated autoclave pretreatment enhances tau immunoreactivity in formalin-fixed normal and Alzheimer's disease brain tissues. Lab Invest (1991) 1.78
The sequential development of abnormal prion protein accumulation in mice with Creutzfeldt-Jakob disease. Am J Pathol (1992) 1.66
Diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Arch Neurol (1996) 1.66
An amber mutation of prion protein in Gerstmann-Sträussler syndrome with mutant PrP plaques. Biochem Biophys Res Commun (1993) 1.63
Identification of two prion protein regions that modify scrapie incubation time. J Virol (2001) 1.63
Creutzfeldt-Jakob disease with florid plaques after cadaveric dural graft in a Japanese woman. Lancet (1997) 1.60
Morphometric comparison of the vulnerability of peripheral motor and sensory neurons in amyotrophic lateral sclerosis. J Neuropathol Exp Neurol (1981) 1.59
Immunohistochemical confirmation of Creutzfeldt-Jakob disease with a long clinical course with amyloid plaque core antibodies. Am J Pathol (1988) 1.52
Accumulation of alpha B-crystallin in central nervous system glia and neurons in pathologic conditions. Am J Pathol (1992) 1.46
Transmission of Creutzfeldt-Jakob disease from human blood and urine into mice. Lancet (1985) 1.46
Novel missense variants of prion protein in Creutzfeldt-Jakob disease or Gerstmann-Sträussler syndrome. Biochem Biophys Res Commun (1993) 1.43
Rosenthal fibers share epitopes with alpha B-crystallin, glial fibrillary acidic protein, and ubiquitin, but not with vimentin. Immunoelectron microscopy with colloidal gold. Am J Pathol (1991) 1.42
Sequence heterogeneity of HTLV-I proviral DNA in the central nervous system of patients with HTLV-I-associated myelopathy. Ann Neurol (1994) 1.38
Codon 219 Lys allele of PRNP is not found in sporadic Creutzfeldt-Jakob disease. Ann Neurol (1998) 1.37
Experimental transmission of human subacute spongiform encephalopathy to small rodents. I. Clinical and histological observations. Acta Neuropathol (1980) 1.31
Formalin fixed brains are useful for magnetic resonance imaging (MRI) study. J Neurol Sci (1987) 1.29
Organ distribution of proteinase-resistant prion protein in humans and mice with Creutzfeldt-Jakob disease. J Gen Virol (1989) 1.24
Amyloid plaques in the brains of mice with Creutzfeldt-Jakob disease. Ann Neurol (1984) 1.23
N-terminal sequence of prion protein is also integrated into kuru plaques in patients with Gerstmann-Sträussler syndrome. Brain Res (1991) 1.23
Immunoblotting of Creutzfeldt-Jakob disease prion proteins: host species-specific epitopes. Ann Neurol (1987) 1.22
Mitochondrial encephalomyopathy with lactate-pyruvate elevation and brain infarctions. Neurology (1984) 1.21
Human prion diseases with variant prion protein. Philos Trans R Soc Lond B Biol Sci (1994) 1.21
The original Gerstmann-Sträussler-Scheinker family of Austria: divergent clinicopathological phenotypes but constant PrP genotype. Brain Pathol (1995) 1.19
Presence of HTLV-I proviral DNA in central nervous system of patients with HTLV-I-associated myelopathy. Ann Neurol (1992) 1.18
Cardiovascular beneficial effects of electroacupuncture at Neiguan (PC-6) acupoint in anesthetized open-chest dog. Jpn J Physiol (2001) 1.17
Increased tau accumulation in senile plaques as a hallmark in Alzheimer's disease. Am J Pathol (1989) 1.16
CJD discrepancy. Nature (1991) 1.16
Ferritin immunohistochemistry as a marker for microglia. Acta Neuropathol (1989) 1.15
Alpha B-crystallin and 27-kd heat shock protein are regulated by stress conditions in the central nervous system and accumulate in Rosenthal fibers. Am J Pathol (1993) 1.14
Interaction of aluminum with PHFtau in Alzheimer's disease neurofibrillary degeneration evidenced by desferrioxamine-assisted chelating autoclave method. Am J Pathol (1999) 1.10
A new inherited prion disease (PrP-P105L mutation) showing spastic paraparesis. Ann Neurol (1993) 1.10
Protective prion protein polymorphisms against sporadic Creutzfeldt-Jakob disease. Lancet (1998) 1.09
Experimental transmission of human subacute spongiform encephalopathy to small rodents. III. Further transmission from three patients and distribution patterns of lesions in mice. Acta Neuropathol (1981) 1.09
Intravascular papillary endothelial hyperplasia. Clin Exp Dermatol (1988) 1.06
Neuronal autophagy in experimental Creutzfeldt-Jakob's disease. Acta Neuropathol (1989) 1.05
Herpes simplex virus type 1 infection in mice with severe combined immunodeficiency (SCID). Arch Virol (1988) 1.05
Alzheimer's amyloid precursor protein accumulates within axonal swellings in human brain lesions. Neurosci Lett (1992) 1.05
Distinctive immunohistochemical profiles of small heat shock proteins (heat shock protein 27 and alpha B-crystallin) in human brain tumors. Cancer (1996) 1.01
Creutzfeldt-Jakob disease patients with congophilic kuru plaques have the missense variant prion protein common to Gerstmann-Sträussler syndrome. Ann Neurol (1990) 1.00
Increased senile plaques without microglia in Alzheimer's disease. Acta Neuropathol (1991) 1.00
Aging and cerebral amyloid: early detection of amyloid in the human brain using biochemical extraction and immunostain. J Gerontol (1988) 0.99
New variant prion protein in a Japanese family with Gerstmann-Sträussler syndrome. Brain Res Mol Brain Res (1995) 0.99
Creutzfeldt-Jakob disease with florid-type plaques after cadaveric dura mater grafting. Arch Neurol (1999) 0.98
A new method to classify amyloid fibril proteins. Acta Neuropathol (1985) 0.98
A prion protein missense variant is integrated in kuru plaque cores in patients with Gerstmann-Sträussler syndrome. Neurology (1991) 0.97
Positive transmission of Creutzfeldt-Jakob disease verified by murine kuru plaques. Lab Invest (1989) 0.96
Spinal cord multiple sclerosis lesions in Japanese patients: Schwann cell remyelination occurs in areas that lack glial fibrillary acidic protein (GFAP). Acta Neuropathol (1985) 0.96
Humanized prion protein knock-in by Cre-induced site-specific recombination in the mouse. Biochem Biophys Res Commun (1996) 0.96
Colocalization of prion protein and beta protein in the same amyloid plaques in patients with Gerstmann-Sträussler syndrome. Acta Neuropathol (1992) 0.96
Sense and antisense modification of glial alpha B-crystallin production results in alterations of stress fiber formation and thermoresistance. J Cell Biol (1994) 0.95
Properties of the transmissible agent derived from chronic spongiform encephalopathy. Ann Neurol (1980) 0.95
The primary structure of the prion protein influences the distribution of abnormal prion protein in the central nervous system. Am J Pathol (1992) 0.94
Accumulation of alpha B-crystallin in brains of patients with Alexander's disease is not due to an abnormality of the 5'-flanking and coding sequence of the genomic DNA. Neurosci Lett (1992) 0.94
Japanese family with Creutzfeldt-Jakob disease with codon 200 point mutation of the prion protein gene. Neurology (1994) 0.94
Ventricular contractility in atrial fibrillation is predictable by mechanical restitution and potentiation. Am J Physiol (1998) 0.93
Immunohistochemical demonstration of alphaB-crystallin in hamartomas of tuberous sclerosis. Am J Pathol (1991) 0.93
Accumulation of abnormal prion protein in mice infected with Creutzfeldt-Jakob disease via intraperitoneal route: a sequential study. Am J Pathol (1993) 0.92
Morphogenesis of amyloid plaques in mice with Creutzfeldt-Jakob disease. Acta Neuropathol (1985) 0.92
MIB1 staining index and scoring of histologic features in meningioma. Indicators for the prediction of biologic potential and postoperative management. Cancer (1994) 0.92
Chordoma in early childhood: a clinicopathological study. Neurosurgery (1991) 0.92
Experimental transmission of h-type bovine spongiform encephalopathy to bovinized transgenic mice. Vet Pathol (2010) 0.92
Expression of neurofibromatosis 2 protein in human brain tumors: an immunohistochemical study. Acta Neuropathol (1997) 0.91
[Atypical Alzheimer's disease--an autopsy case]. No To Shinkei (1976) 0.91
Familial Creutzfeldt-Jakob disease with D178N-129M mutation of PRNP presenting as cerebellar ataxia without insomnia. J Neurol Neurosurg Psychiatry (2000) 0.91
Experimental transmission of human subacute spongiform encephalopathy to small rodents. II. Ultrastructural study of spongy state in the gray and white matter. Acta Neuropathol (1980) 0.91
Host genetic control of incubation periods of Creutzfeldt-Jakob disease in mice. J Gen Virol (1989) 0.91
Protective effect of recombinant murine interferon beta against mouse hepatitis virus infection. Antiviral Res (1987) 0.91
[The pathology of the peripheral nervous system in two autopsy cases of osteosclerotic myeloma associated with polyneuropathy, skin hyperpigmentation, hypertrichosis and edema (author's transl)]. Rinsho Shinkeigaku (1980) 0.91
Prion disease with 144 base pair insertion in a Japanese family line. Acta Neuropathol (1995) 0.90
A comparative immunohistochemical study of Kuru and senile plaques with a special reference to glial reactions at various stages of amyloid plaque formation. Am J Pathol (1991) 0.90
Parvalbumin-immunoreactive neurons in the human central nervous system are decreased in Alzheimer's disease. Acta Neuropathol (1991) 0.90
A morphometric study of myelinated fibers in the fifth lumbar ventral roots in patients with cerebrovascular diseases. Clin Neuropathol (1988) 0.90
Creutzfeldt-Jakob disease with codon 129 polymorphism (valine): a comparative study of patients with codon 102 point mutation or without mutations. Acta Neuropathol (1992) 0.90
Successful transmission of Creutzfeldt-Jakob disease from human to mouse verified by prion protein accumulation in mouse brains. Brain Res (1992) 0.90
Clinical course of patients with coronary ectasia. Cardiology (1999) 0.90
[Electrocardiographic criteria for the diagnosis of the left septal fascicular block and its frequency among primarily elderly hospitalized patients]. Nihon Ronen Igakkai Zasshi (1992) 0.90
Adrenoleukodystrophy with olivopontocerebellar atrophy-like lesions. Clin Neuropathol (1986) 0.89
Amyloid beta-protein (Abeta) 1-40 but not Abeta1-42 contributes to the experimental formation of Alzheimer disease amyloid fibrils in rat brain. J Neurosci (1997) 0.89
Antigen retrieval using sodium hydroxide for prion immunohistochemistry in bovine spongiform encephalopathy and scrapie. J Comp Pathol (2010) 0.89
Effects of skin metabolism on percutaneous penetration of lipophilic drugs. J Pharm Sci (1997) 0.88
Expression and targeting of Syrian hamster prion protein induced by heat shock in transgenic Drosophila melanogaster. Mech Dev (1995) 0.87
Detection of disease-associated prion protein in the posterior portion of the small intestine involving the continuous Peyer's patch in cattle orally infected with bovine spongiform encephalopathy agent. Transbound Emerg Dis (2011) 0.87
The presence of complements in amyloid plaques of Creutzfeldt-Jakob disease and Gerstmann-Straussler-Scheinker disease. Appl Pathol (1984) 0.87